Followers | 4054 |
Posts | 151,292 |
Boards Moderated | 4 |
Alias Born | 08/05/2009 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
nope sold, here the highest price I got
$NVAX glad I sold those when I did pic.twitter.com/7xRr8WA4P9
— THE FINAL COUNTDOWN (@READY_2_PROFIT) May 10, 2024
Rough timeline from the earnings call for $CLSK to have their 2 new sites outside of Cheyenne up and running. I also mixed in a little speculative DD of my own into the business I believe they bought. Those parts are unconfirmed, but it all adds up:
— D.R. Lewis ⚡ (@Charge_Stack) May 10, 2024
1. Close in ~45 days = end… https://t.co/GxUTvdWOEI
2.50
THE MOONMARKET EFFECT
NVAX HALT??? COMING
CONGRAT$ ON THAT CALL
Major Developments
5/10/2024, 6:06:45 AMLicensing deal with Sanofi, $500m upfront and $700m for development.
https://dilutiontracker.com/app/search/NVAX
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
https://finance.yahoo.com/news/sanofi-inks-1-2-billion-082615895.html
JUST IN: Huge news from #Novavax ( $NVAX) as they announce a game-changing $1.4 billion deal with Sanofi ( $SNY) 🚀🔬
— Antonio Santiago (@awsan) May 10, 2024
💸 Partnership Perks:
Sanofi to invest $500M upfront, promising another $700M for hitting key milestones. Plus, an additional $200M to adopt Novavax’s Matrix-M… pic.twitter.com/MpqMqePkcd
thats more than a morning pump
Major Developments
5/10/2024, 6:06:45 AMLicensing deal with Sanofi, $500m upfront and $700m for development.
https://dilutiontracker.com/app/search/NVAX
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
https://finance.yahoo.com/news/sanofi-inks-1-2-billion-082615895.html
JUST IN: Huge news from #Novavax ( $NVAX) as they announce a game-changing $1.4 billion deal with Sanofi ( $SNY) 🚀🔬
— Antonio Santiago (@awsan) May 10, 2024
💸 Partnership Perks:
Sanofi to invest $500M upfront, promising another $700M for hitting key milestones. Plus, an additional $200M to adopt Novavax’s Matrix-M… pic.twitter.com/MpqMqePkcd
OK but it sounded like you were saying they released an copy of an old PR, I looked and didnt see... so thats why I asked
but do see where they by their own admission said it was something that had happened in March
Thanks for the commentary, I believe you missed your calling in media/marketing
btw I didnt read the FULL pr
but I will say you saved me some money, because after I read your post I sold @ 1.91
and now its 1.57👍️
$LIDR 1.57 glad I sold last night thanks to seeing this post on investor hubhttps://t.co/nFDmVsXyLK pic.twitter.com/1y7mBmFCvi
— THE FINAL COUNTDOWN (@READY_2_PROFIT) May 10, 2024
HOW MUCH TIME DO YOU HAVE?
Im impressed with you work
$RNAZ good call
Message in reply to:
RNAZ .92 +’13% look for 1.09 again
please show us where the news is the same https://ih.advfn.com/stock-market/NASDAQ/aeye-LIDR/news
that happened yesterday
$CLSK Earnings and Reaction 🐺
— Nostradamus (@RareSterling) May 9, 2024
Put the cork back in the champagne 🍾 “Charts Don’t Lie” ride redline📉 pic.twitter.com/Fb2zUMChfy
$CLSK's Q2 FY2024 financial results ended March 31, 2024:
*Revenue: $111.8 million
*Net Income: $126.7 million
*Adjusted EBITDA: $181.8 million
*Total Assets: $1.54 billion
Revenue grew by 163% YoY and our current #bitcoin mining #hashrate surpasses 17 EH/s.
Read the full press release here: https://bit.ly/3ycMzXi
Introducing $CLSK's Q2 FY2024 financial results ended March 31, 2024:
— CleanSpark Inc. (@CleanSpark_Inc) May 9, 2024
*Revenue: $111.8 million
*Net Income: $126.7 million
*Adjusted EBITDA: $181.8 million
*Total Assets: $1.54 billion
Revenue grew by 163% YoY and our current #bitcoin mining #hashrate surpasses 17 EH/s.
Read… pic.twitter.com/sKOAnIGEIy
The concession stand is way overpriced but a big money maker for them
what could the popcorn cost to make
https://www.amctheatres.com/food-and-drink
$ivp moonmarket does it aGAIN
the kid has algos triggered on his alerts
$ivp moonmarket does it aGAIN
the kid has algos triggered on his alerts
I dunno, but what I do know is the snack counter will hurt your pocket
its late
I thought you said king dingo😆
GOOD EARNINGS VS NO EARNINGS.
— Tzvika Perelman (@TzvikaPerelman) May 8, 2024
PLEASE MAKE IT MAKE SENSE.$AMC #AMC pic.twitter.com/LtEyEYLi1Y
$AMC has beaten analyst earnings estimates for 12 quarters in a row.
— Jυввiη🪐 (@flop4me) May 8, 2024
Yes, twelve.
Ebullient. #AMC 💯
Thank you https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174382614
$CTMX hilarious price action. From press release, it was obvious partial responses were seen in pancreatic cancer and not yet in other cancers. Those partial responses are ongoing. Yet after a waterfall plot is shown market is newly skittish ?
— avidresearch (@avidresearch) May 8, 2024
did you witness todays MADNE$$
$CTMX learned the hard way , lost money on many Phase I stocks
MY ADVICE IS ITS BEST TO JUST STAY AWAY FROM MOST PHASE I STOCKS ALL TOGETHER
this ones news sounds weak
https://www.globenewswire.com/news-release/2024/05/08/2878255/37704/en/CytomX-Therapeutics-Announces-Positive-Initial-Phase-1a-Dose-Escalation-Data-for-Monotherapy-CX-904-EGFRxCD3-PROBODY-T-Cell-Engager.html
dose escalation?
$CTMX its CX-904, T-cell engager, only works for pancreatic cancer? It appears not effective for CRC, gastric, esophageal, NSCLC, HNSCC, why? forget this one. Be long $JANX and $LVTX
— Nick zheng (@pick1998_2) May 8, 2024
$CTMX Down 40%. You can celebrate two PRs though. 😂 https://t.co/OZLhxKdGrm
— Alp Bugra Basat, MD (@AlpBugraBasat) May 8, 2024
$ctmx 4 to 9 then hellacious fall to 2 thoughts anyone?
basically went all the way back to its offering price almost a year ago
Private Placement 14,423,077 $2.08 11,538,462 $30,000,000 BVF 2023-6-30 8:00
https://dilutiontracker.com/app/search/CTMX
$CTMX +83% AH, EGFRxCD3 surprising findings:
— BayAreaBiotechI (@BayAreaBiotechI) May 8, 2024
1. It's a masked Probody but they are still step dosing and using tocilizumab prophylaxis
2. From a basket of EGFR+ cancers, the only PRs are in panc?? CRC, NSCLC, HNSCC, gastric, and esophageal all enrolled $JANX pic.twitter.com/NWjmqbZDV9
CTMX that was CRAZEEEEEEEEEEEEEEEEEEEEEEEE
anything is possible in this crazy market
$PEGY lets do it! https://t.co/Zh8z7JUXWT
— Marici (@BreedingMoney) May 7, 2024
PEGY .0777
what is a DNR list
$BVS - Bioventus GAAP EPS of -$0.07 beats by $0.18, revenue of $129.45M beats by $11.07M https://t.co/IGk1Zy2r5X
— Seeking Alpha Market News (@MarketCurrents) May 7, 2024
3.33-2.03 ***ITS A TRAP****
$eldn 2.22 oversubscribed turd
— THE FINAL COUNTDOWN (@READY_2_PROFIT) May 7, 2024
now red after hitting 3.33 on news, heres the 2nd PRhttps://t.co/3DcVJcaDnN(NASDAQ,development%20for%20the%20prevention%20of
$eldn 2.22 oversubscribed turd
— THE FINAL COUNTDOWN (@READY_2_PROFIT) May 7, 2024
now red after hitting 3.33 on news, heres the 2nd PRhttps://t.co/3DcVJcaDnN(NASDAQ,development%20for%20the%20prevention%20of
$SGE nice alert @ 1.33 CONGRAT$
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174110430&txt2find=sge
+$3k
$BENF probably the most scary stock I've seen in awhile. Skippy, halts, Expensive RegSHO borrows. Total degeneracy on full display https://t.co/12JOL9Jdui
— madaz (@madaznfootballr) May 3, 2024
5.72 MADNE$$
#SHORT
1.27
SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level $SLS https://t.co/bQBsEQo7jc
— Health Stocks News (@health_stocks) May 1, 2024